tenofovir has been researched along with mdv 3100 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Cattaneo, D; Cinausero, M; Fusi, M; Gervasoni, C; Londero, A; Tascini, C | 1 |
2 other study(ies) available for tenofovir and mdv 3100
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Effects of the androgen receptor inhibitor enzalutamide on the pharmacokinetics of dolutegravir and tenofovir: a case report.
Topics: Androgen Receptor Antagonists; Benzamides; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Male; Middle Aged; Nitriles; Oxazines; Phenylthiohydantoin; Piperazines; Prostatic Neoplasms; Pyridones; Receptors, Androgen; Tenofovir | 2022 |